ProfileGDS4718 / 222486_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 25% 32% 54% 32% 28% 11% 25% 28% 33% 24% 27% 28% 25% 19% 22% 34% 28% 28% 21% 44% 27% 31% 32% 33% 29% 19% 34% 17% 32% 19% 17% 31% 32% 21% 20% 30% 28% 30% 29% 74% 37% 21% 32% 20% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.3457525
GSM549102patient 115, normal, homogenized [OPG study]4.6274532
GSM549104patient 119, normal, homogenized [OPG study]5.7244654
GSM549108patient 138, normal, homogenized [OPG study]4.6861932
GSM549119patient 077, normal, homogenized [OPG study]4.4571828
GSM549133patient 032, cancer, homogenized [OPG study]3.7884111
GSM549139patient 042, cancer, homogenized [OPG study]4.3138725
GSM549099patient 107, normal, homogenized [OPG study]4.4957228
GSM549109patient 139, normal, homogenized [OPG study]4.6838233
GSM549110patient 046, normal, homogenized [OPG study]4.289624
GSM549114patient 063, normal, homogenized [OPG study]4.3928927
GSM549122patient 082, normal, homogenized [OPG study]4.4677328
GSM549134patient 033, cancer, homogenized [OPG study]4.3266125
GSM549136patient 036, cancer, homogenized [OPG study]4.0641819
GSM549140patient 044, cancer, homogenized [OPG study]4.1743722
GSM549111patient 047, normal, homogenized [OPG study]4.6804934
GSM549113patient 057, normal, homogenized [OPG study]4.3997928
GSM549132patient 031, cancer, homogenized [OPG study]4.4574828
GSM549137patient 038, cancer, homogenized [OPG study]4.1606621
GSM549142patient 047, cancer, homogenized [OPG study]5.3357144
GSM549100patient 110, normal, homogenized [OPG study]4.4382927
GSM549107patient 135, normal, homogenized [OPG study]4.5461331
GSM549115patient 068, normal, homogenized [OPG study]4.5615632
GSM549116patient 072, normal, homogenized [OPG study]4.6271733
GSM549120patient 078, normal, homogenized [OPG study]4.4843229
GSM549131patient 030, cancer, homogenized [OPG study]4.0764919
GSM549118patient 074, normal, homogenized [OPG study]4.7258634
GSM549129patient 027, cancer, homogenized [OPG study]4.0636517
GSM549123patient 088, normal, homogenized [OPG study]4.5848232
GSM549124patient 006, cancer, homogenized [OPG study]4.1547619
GSM549126patient 015, cancer, homogenized [OPG study]4.0366117
GSM549128patient 025, cancer, homogenized [OPG study]4.5766331
GSM549103patient 117, normal, homogenized [OPG study]4.6710532
GSM549117patient 073, normal, homogenized [OPG study]4.1825521
GSM549138patient 041, cancer, homogenized [OPG study]4.1348120
GSM549141patient 045, cancer, homogenized [OPG study]4.4889230
GSM549130patient 028, cancer, homogenized [OPG study]4.4660428
GSM549101patient 111, normal, homogenized [OPG study]4.5637230
GSM549105patient 128, normal, homogenized [OPG study]4.5205729
GSM549106patient 134, normal, homogenized [OPG study]7.3874774
GSM549112patient 048, normal, homogenized [OPG study]4.8386437
GSM549125patient 011, cancer, homogenized [OPG study]4.2054921
GSM549127patient 024, cancer, homogenized [OPG study]4.623132
GSM549135patient 035, cancer, homogenized [OPG study]4.0890920